MSL
DCPH

Mackay Shields LLC’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Mackay Shields LLC’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-28,200
Closed -$1.26M – 1391
2021
Q1 		$1.26M Sell
28,200
-9,500
-25% -$442K 0.01% 932
2020
Q4 		$2.15M Sell
37,700
-5,000
-12% -$296K 0.01% 826
2020
Q3 		$2.19M Buy
42,700
+19,500
+84% +$955K 0.01% 752
2020
Q2 		$1.39M Buy
+23,200
New +$1.24M 0.01% 911

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Mackay Shields LLC's DCPH Position: Q2 2021 in Review

Mackay Shields LLC sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 28,200 shares — an estimated $1.26M sold.

Mackay Shields LLC first reported a position in DCPH in Q2 2020 and held it in 4 quarters. The position peaked at $2.19M in Q3 2020. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

  • Mackay Shields LLC reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 28,200 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $1.26M.
  • Mackay Shields LLC first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Mackay Shields LLC's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.19M in Q3 2020.
  • 147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.